Repeat reduction surgery after an initial hepatectomy for patients with colorectal cancer

Oncology Reports

Volumn 18, Issue 1, 2007, Pages 189-194

  Matsuda, Kenji ^a   Hotta, Tsukasa ^a   Uchiyama, Kazuhisa ^a   Tani, Masaji ^a   Takifuji, Katsunari ^a   Yokoyama, Shozo ^a   Higashiguchi, Takashi ^a   Tominaga, Toshiji ^a   Oku, Yoshimasa ^a   Nasu, Toru ^a   Yamaue, Hiroki ^a  

^a WAKAYAMA MEDICAL UNIVERSITY   (Japan)

Author keywords

Colorectal cancer; Liver metastases; Repeat reduction surgery

Indexed keywords

ADJUVANT CHEMOTHERAPY; AGED; ARTICLE; CANCER STAGING; COLORECTAL TUMOR; FEMALE; HUMAN; LIVER RESECTION; LIVER TUMOR; MALE; METASTASIS; MULTIMODALITY CANCER THERAPY; PATHOLOGY; PROGNOSIS; REOPERATION; SURVIVAL RATE; TIME; TREATMENT OUTCOME; TUMOR RECURRENCE;

AGED; CHEMOTHERAPY, ADJUVANT; COLORECTAL NEOPLASMS; COMBINED MODALITY THERAPY; FEMALE; HEPATECTOMY; HUMANS; LIVER NEOPLASMS; MALE; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PROGNOSIS; REOPERATION; SURVIVAL RATE; TIME FACTORS; TREATMENT OUTCOME;

EID: 34548024900     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.18.1.189     Document Type: Article

References (28)

1. Choti MA, Sitzmann JV, Tiburi MF, et al: Trends in long-term survival following liver resection for hepatic colorectal metastases. Ann Surg 235: 759-766, 2002. (Pubitemid 34547293)
2. Fong Y, Fortner J, Sun RL, Brennan MF and Blumgard LH: Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases. Ann Surg 230: 309-321, 1999. (Pubitemid 30191861)
3. Minagawa M, Makuuchi M, Torzilli G, et al: Extension of the frontiers of surgical indications in the treatment of liver metastases from colorectal cancer. Ann Surg 231: 487-499, 2000. (Pubitemid 30185854)
4. Scheele J, Stang R, Altendorf-Hofmann A, et al: Resection of colorectal liver metastasis. World J Surg 19: 59-71, 1995.
5. Nordinger B, Guiguet M, Vaillant JC, et al: Surgical resection of colorectal carcinoma metastasis to the liver. Cancer 77: 1254-1262, 1996.
6. Kato T, Yasui K, Hirai T, et al: Therapeutic results for hepatic metastasis of colorectal cancer with special reference to effectiveness of hepatectomy: analysis of prognostic factors for 763 cases recorded at 18 institutions. Dis Colon Rectum 46 (suppl): 22-31, 2003.
7. Petrowsky H, Gonen M, Jarnagin W, et al: Second liver resections are a safe and effective treatment for recurrent hepatic metastases from colorectal cancer: A bi-institutional analysis. Ann Surg 235: 863-871, 2002. (Pubitemid 34547306)
8. Takahashi S, Inoue K, Konishi M, Nakagouri T and Kinoshita T: Prognostic factors for poor survival after repeat hepatectomy in patients with colorectal liver metastases. Surgery 133: 627-634, 2003. (Pubitemid 36688317)
9. Suzuki S, Sakaguchi T, Yokoi Y, et al: Impact of repeat hepatectomy on recurrent colorectal liver metastases. Surgery 129: 421-428, 2001. (Pubitemid 32289891)
10. Sugawara G, Isogai M, Kaneoka Y, Suzuki M and Yamaguchi A: Repeat hepatectomy for recurrent colorectal metastases. Surg Today 35: 282-289, 2005. (Pubitemid 40562193)
11. Kin T, Nakajima Y, Kanehiro H, et al: Repeat hepatectomy for recurrent colorectal metastases. World J Surg 22: 1087-1091, 1998. (Pubitemid 28428057)
12. Adam R, Bismuth H, Castaing D, et al: Repeat hepatectomy for colorectal liver metastases. Ann Surg 225: 51-60, 1997.
13. Shaw IM, Rees M, Welsh FK, Bygraves S and John TG: Repeat hepatic resection for recurrent colorectal liver metastases is associated with favourable long-term survival. Br J Surg 93: 457-464, 2006.
14. Lehnert T, Knaebel HP, Duck M, Bulzelbruck H and Herfarth C: Sequential hepatic and pulmonary resections for metastatic colorectal cancer. Br J Surg 86: 241-243, 1999. (Pubitemid 29090192)
15. Regnard JF, Grunenwald D, Spaggiari L, et al: Surgical treatment of hepatic and pulmonary metastases from colorectal cancers. Ann Thorac Surg 66: 214-218, 1998. (Pubitemid 28389261)
16. Robinson BJ, Rice TW, Strong SA, Rybicki LA and Blackstone EH: Is resection of pulmonary and hepatic metastases warranted in patients with colorectal cancer? J Thorac Cardiovasc Surg 117: 66-75, 1999.
17. Ambiru S, Miyazaki M, Ito H, et al: Resection of hepatic and pulmonary metastases in patients with colorectal carcinoma. Cancer 82: 274-278, 1998. (Pubitemid 28060242)
18. Fukunaga K, Takada Y, Otsuka M, Todoriki T and Fukao K: Resection of localized recurrences after hepatectomy of colorectal cancer metastases. Hepatogastroenterology 50: 1894-1897, 2003. (Pubitemid 37467957)
19. Nagakura S, Shirai Y, Suda T and Hatakeyama K: Multiple repeat resection of intra- and extrahepatic recurrences in patients undergoing initial hepatectomy for colorectal metastases. World J Surg 26: 141-147, 2002. (Pubitemid 36920423)
20. Mutsaerts E, Ruth S, Zoetmulder F, Rutgers E, Hart A and Coevorden F: Prognostic factors and evaluation of surgical management of hepatic metastases from colorectal origin: A 10-year single-institute experience. J Gastrointest Surg 9: 178-186, 2005. (Pubitemid 40202975)
21. Tournigand C, Andre T, Achille E, et al: FOLFIRI followed by FOLFOX6 or the reverse sequence in advanced colorectal cancer: a randomized GERCOR study. J Clin Oncol 22: 229-237, 2004. (Pubitemid 41095086)
22. Goldberg RM, Sargent DJ, Morton RF, et al: A randomized controlled trial of fluorouracil plus leucovorin, irinotecan, oxaliplatin combinations in patients with previously untreated metastatic colorectal cancer. J Clin Oncol 22: 23-30, 2004. (Pubitemid 41095110)
23. Hurwitz H, Fehrenbacher L, Novotny W, et al: Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer. N Engl J Med 350: 2335-2342, 2004. (Pubitemid 38702844)
24. Hotta T, Takifuji K, Uchiyama K, Yokoyama S, Matsuda K, Higashiguchi T, Tominaga T, Oku Y, Nasu T and Yamaue H: Potential predictors of survival after surgery for colorectal cancer patients with synchronous unresectable liver metastases. Oncol Rep 16: 1369-1374, 2006.
25. Truant S, Huglo D, Hebbar M, Ernst O, Steinling M and Pruvot FR: Prospective evaluation of the impact of [18F] fluoro-2-deoxy-D-glucose positron emission tomography of respectable colorectal liver metastases. Br J Surg 92: 362-369, 2005. (Pubitemid 40445601)
26. Ruers TJM, Langenhoff BS, Neeleman N, et al: Value of positron emission tomography with [18F] fluorodeoxyglucose in patients with colorectal liver metastases: A prospective study. J Clin Oncol 20: 388-395, 2002. (Pubitemid 34072520)
27. Selzner M, Hany TF, Wildbrett P, McCormack L, Kadry Z and Clavien PA: Does the novel PET/CT imaging modality impact on the treatment of patients with metastatic colorectal cancer of the liver? Ann Surg 240: 1027-1036, 2004. (Pubitemid 39602130)
28. Fernandez FG, Drebin JA, Linehan DC, Dehdashti F, Siegel BA and Strasberg SM: Five-year survival after resection of hepatic metastases from colorectal cancer in patients screened by positron emission tomography with F-18 fluorodeoxyglucose (FDG-PET). Ann Surg 240: 438-450, 2004. (Pubitemid 39121338)